UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
April 25, 2023
Accession Number:
0001493152-23-013010
Submission Type:
POS AM
CIK:
0000908259
Company Name:
Oncotelic Therapeutics, Inc.
File Number:
333-256448